Clinical Trial Update: GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating GLP-1 receptor agonist therapy on IL-6 signaling and adipose tissue remodeling to modulate metabolic response in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance
• Obesity

Drugs mentioned

• GLP-1 receptor agonist therapy (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Glucose Intolerance, Overweight and Obesity | Phase 4 | Status: COMPLETED | Results posted: 2024-12-05